Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. Inst. Med. Trop. Säo Paulo ; 43(3): 153-159, May-June 2001. ilus, tab
Artículo en Inglés | LILACS | ID: lil-298906

RESUMEN

The circumoval precipitin test (COPT), enzyme-linked immunosorbent assay (ELISA) and the immunoblotting anti-adult worm antigen (AWA) and soluble egg antigen (SEA) tests were applied to 17 chronically schistosome-infected patients for the detection of anti-Schistosoma mansoni antibodies before and on four occasions after oxamniquine administration over a period of six months. Compared to a control group, schistosomiasis patients showed high levels of IgG antibodies in AWA and SEA-ELISA. A decrease in IgG levels was observed six months after treatment, although negative reactions were not obtained. Significant decreases in IgG1, IgG3 and, mainly, IgG4, but not anti-SEA IgG2 levels were observed six months after treatment, again without negativity. Analysis of anti-AWA IgG antibodies by immunoblotting before treatment showed a 31 kDa strand in 14 patients (82 percent) which disappeared in three cases up to six months after treatment; furthermore, anti-SEA IgG antibodies showed the same band in nine patients (53 percent) before treatment, which disappeared in only four cases up to six months after treatment


Asunto(s)
Humanos , Animales , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anticuerpos Antihelmínticos/sangre , Inmunoglobulina G/sangre , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/inmunología , Análisis de Varianza , Antígenos Helmínticos , Enfermedad Crónica , Ensayo de Inmunoadsorción Enzimática , Estudio de Evaluación , Estudios de Seguimiento , Immunoblotting , Oxamniquina/uso terapéutico , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomicidas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA